What is the recommended management for acute frontal sinusitis, including first‑line antibiotics, supportive therapy, and criteria for surgical referral?

Treatment of Frontal Sinusitis

First-Line Antibiotic Therapy

For uncomplicated acute frontal sinusitis in adults, prescribe amoxicillin-clavulanate 875 mg/125 mg twice daily for 10–14 days (or until symptom-free for 7 consecutive days), which provides 90–92% predicted clinical efficacy against the major pathogens. 1

• Frontal sinusitis carries a higher risk of serious complications (intracranial extension, osteomyelitis of the frontal bone, epidural empyema) compared to maxillary sinusitis, so aggressive initial therapy is warranted. 2, 3, 4
• The microbiology of acute frontal sinusitis is dominated by Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus; amoxicillin-clavulanate covers β-lactamase-producing H. influenzae and Moraxella catarrhalis that plain amoxicillin misses. 1, 5
• High-dose amoxicillin-clavulanate (2 g/125 mg twice daily) should be used when any of the following risk factors are present: recent antibiotic use (≤4–6 weeks), age >65 years, daycare exposure, moderate-to-severe symptoms, comorbidities (diabetes, chronic cardiac/hepatic/renal disease), or immunocompromised state. 1

Alternative Regimens for Penicillin Allergy

• For non-severe (non-type I) penicillin allergy: use a second- or third-generation cephalosporin (cefuroxime-axetil, cefpodoxime-proxetil, cefdinir, or cefprozil) for 10 days; cross-reactivity with penicillins is negligible (<1%). 1
• For severe (type I/anaphylactic) penicillin allergy: prescribe a respiratory fluoroquinolone—levofloxacin 500 mg once daily for 10–14 days or moxifloxacin 400 mg once daily for 10 days—both achieving 90–92% predicted efficacy against multidrug-resistant S. pneumoniae and β-lactamase-producing organisms. 1
• Reserve fluoroquinolones for severe penicillin allergy or documented treatment failure to limit resistance development; they should not be used as routine first-line therapy. 1

Essential Adjunctive Therapies (Add to All Patients)

• Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and accelerate symptom resolution; supported by strong evidence from multiple randomized controlled trials. 1
• Saline nasal irrigation 2–3 times daily provides symptomatic relief and enhances mucus clearance. 1
• Analgesics (acetaminophen or ibuprofen) for pain and fever control. 1
• Adequate hydration, warm facial packs, and sleeping with the head elevated are recommended supportive measures. 1

Monitoring and Reassessment Protocol

• Reassess at 3–5 days: If no clinical improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch immediately to high-dose amoxicillin-clavulanate or a respiratory fluoroquinolone. 1
• Reassess at 7 days: Persistent or worsening symptoms warrant confirmation of diagnosis, exclusion of complications (orbital cellulitis, meningitis, intracranial abscess, frontal bone osteomyelitis), and consideration of imaging or ENT referral. 1
• Expected timeline: Noticeable improvement should occur within 3–5 days of appropriate therapy, with complete resolution by 10–14 days or when symptom-free for 7 consecutive days. 1

Imaging and Diagnostic Considerations

• CT scan (preferably coronal thin-cut) of the head, orbits, and sinuses is essential when complications are suspected (severe headache, altered mental status, visual changes, periorbital swelling, Pott's puffy tumor). 2
• MRI may be desirable in cases of suspected intracranial abnormality (epidural or subdural abscess, brain abscess, venous thrombosis, meningitis). 2
• Routine imaging is not recommended for uncomplicated frontal sinusitis; up to 87% of viral upper-respiratory infections show sinus abnormalities on imaging, leading to unnecessary interventions. 1

Criteria for Urgent Surgical Referral

Immediate otolaryngology (and neurosurgery when indicated) consultation is required for any of the following:

• Intracranial complications: altered mental status, severe headache, Pott's puffy tumor (osteomyelitis of the frontal bone), signs of meningitis, epidural or subdural abscess, brain abscess, venous thrombosis. 2, 3, 4
• Orbital complications: proptosis, impaired visual acuity, impaired and/or painful extraocular mobility, periorbital swelling/erythema, diplopia. 2
• No improvement after 7 days of appropriate second-line antibiotic therapy. 1
• Worsening symptoms at any point during treatment (increasing facial pain, fever, purulent drainage). 1
• Recurrent frontal sinusitis (≥3 episodes per year) requiring evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities. 2, 1

Inpatient Management for Complicated Frontal Sinusitis

• Hospitalize immediately if proptosis, impaired visual acuity, impaired/painful extraocular mobility, altered mental status, severe headache, or Pott's puffy tumor is present. 2
• Intravenous antibiotics should be started immediately upon suspicion of intracranial or intraorbital complications, before imaging confirmation. 2
• Appropriate antimicrobial therapy for intraorbital complications includes vancomycin (to cover possible methicillin-resistant S. pneumoniae) and should be tailored to culture and sensitivity results when available. 2
• Consultation with otolaryngology, ophthalmology, and infectious disease is appropriate for guidance regarding surgical intervention and antibiotic selection. 2
• Combined surgical approach (external frontoethmoidectomy with mucoperiostectomy, followed by endoscopic sinus surgery for intranasal ethmoidectomy) may be required for extensive complications. 6, 3
• Intravenous antibiotic duration: typically 3 weeks, followed by additional oral antibiotics for 5 weeks in cases with extensive abscess and osteomyelitis. 6

Surgical Techniques and Indications

• Functional endoscopic sinus surgery (FESS) is indicated when nasal polyps obstruct sinus drainage despite medical treatment, when recurrent or persistent infectious sinusitis fails adequate medical management, or when anatomic defects obstruct the sinus outflow tract. 2
• Balloon sinuplasty may be considered for acute frontal sinusitis requiring surgical drainage; it enlarges the sinus ostium by effecting tiny fractures of surrounding bone and compressing soft tissue without removing mucosa. 7
• Frontal sinus obliteration with fat remains a viable consideration when revised surgical intervention fails to resolve chronic frontal sinusitis. 2
• Surgery should be offered when expected benefits clearly outweigh those achievable with medical therapy alone, when expected outcomes are well defined, and when the patient understands long-term management expectations. 8

Critical Pitfalls to Avoid

• Do not prescribe antibiotics for symptoms <10 days unless severe features (fever ≥39°C with purulent discharge for ≥3 consecutive days) are present; approximately 98–99.5% of acute rhinosinusitis is viral and resolves spontaneously. 1
• Do not delay escalation beyond 3–5 days in non-responders; delayed therapy increases the risk of serious complications such as intracranial extension or frontal bone osteomyelitis. 1, 3, 4
• Avoid macrolides (azithromycin, clarithromycin) due to 20–25% resistance rates in S. pneumoniae and H. influenzae. 1
• Avoid trimethoprim-sulfamethoxazole due to ≈50% resistance in S. pneumoniae and ≈27% in H. influenzae. 1
• Ensure adequate treatment duration (minimum 10–14 days for frontal sinusitis) to prevent relapse and complications. 1
• Recognize that frontal sinusitis in adolescent males is particularly prone to intracranial complications and requires heightened vigilance. 2

Special Populations

Pediatric Considerations

• High-dose amoxicillin-clavulanate: 80–90 mg/kg/day (amoxicillin component) with 6.4 mg/kg/day clavulanate divided twice daily for children with risk factors (age <2 years, daycare attendance, recent antibiotic use). 1
• Treatment duration: minimum 10–14 days (longer than adult courses). 1
• Reassess at 72 hours: if no improvement or worsening, switch to high-dose amoxicillin-clavulanate. 1
• Ceftriaxone 50 mg/kg IM or IV once daily for children unable to tolerate oral medication. 1

Chronic Frontal Sinusitis

• First-line medical therapy: high-volume saline nasal irrigation combined with intranasal corticosteroids forms the cornerstone of management. 8
• Long-term antibiotic therapy (>12 weeks) has Level Ib evidence for preventing late polyp recurrence in chronic rhinosinusitis with nasal polyps. 8
• Evaluate for underlying conditions: allergic rhinitis, immunodeficiency, gastroesophageal reflux disease (GERD), aspirin sensitivity. 8
• FESS should be offered when medical therapy fails to achieve satisfactory control, when anatomic obstruction is present, or when nasal polyps do not respond to medical therapy. 8

Prognosis and Outcomes

• Disease-related mortality and severe long-term morbidity can be minimized to 0% if frontal sinusitis complications are detected and treated early with aggressive antibiotic and combined surgical treatment. 3
• Major complications after sinus surgery occur in less than 1% of cases. 8
• Approximately 10% of patients require revision sinus surgery within three years of the initial procedure. 8
• Close cooperation with neurosurgery, ophthalmology, and radiology is of utmost importance for optimal outcomes. 3